Location History:
- Sart-Tilman, BE (2016)
- Herstal, BE (2018)
Company Filing History:
Years Active: 2016-2018
Title: Valerie Deregowski: Innovator in Cervical Cancer Detection
Introduction
Valerie Deregowski is a prominent inventor based in Herstal, Belgium. She has made significant contributions to the field of medical diagnostics, particularly in the detection and prognosis of cervical cancer. With a total of 2 patents to her name, her work is paving the way for advancements in cancer research and treatment.
Latest Patents
Deregowski's latest patents focus on innovative methods for identifying and monitoring cervical cancer. One of her notable inventions is related to the methylation of the EPB41L3 gene or its promoter in test samples comprising cervical cells. This invention provides methods and kits for diagnosing and prognosing cervical cancer by determining the methylation status or expression levels of specific genes. Another patent addresses the detection and prognosis of cervical cancer, utilizing similar methodologies to enhance diagnostic accuracy.
Career Highlights
Throughout her career, Valerie has worked with notable companies such as MDxHealth SA. Her expertise in molecular diagnostics has positioned her as a key player in the medical research community. Her contributions are instrumental in developing effective diagnostic tools that can significantly impact patient outcomes.
Collaborations
Deregowski has collaborated with esteemed colleagues, including Wim Van Criekinge and Luc Dehaspe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of cancer research.
Conclusion
Valerie Deregowski's work in cervical cancer detection exemplifies the importance of innovation in medical diagnostics. Her patents and collaborations highlight her commitment to improving healthcare outcomes through scientific research.